CoChat

The changing epidemiology of Plasmodium vivax: Insights from conventional and novel surveillance tools

Auburn, Sarah, Cheng, Qin, Marfurt, Jutta, Price, Ric N. · 2021 · PLOS Medicine
Cited by 45

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1003560

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 114

  1. RN Price, 2020, Plasmodium vivax in the Era of the Shrinking P. falciparum Map, Trends Parasitol, 36, 560, 10.1016/j.pt.2020.03.009 · DOI · Paper page
  2. RN Price, 2014, Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis, Lancet Infect Dis, 14, 982, 10.1016/S1473-3099(14)70855-2 · DOI · Paper page
  3. NJ White, 2016, Why Do Some Primate Malarias Relapse?, Trends Parasitol, 32, 918, 10.1016/j.pt.2016.08.014 · DOI
  4. RJ Commons, 2020, Estimating the Proportion of Plasmodium vivax Recurrences Caused by Relapse: A Systematic Review and Meta-Analysis, Am J Trop Med Hyg, 103, 1094, 10.4269/ajtmh.20-0186 · DOI · Paper page
  5. S Dini, 2020, The risk of morbidity and mortality following recurrent malaria in Papua, Indonesia: a retrospective cohort study., BMC Med., 18, 28, 10.1186/s12916-020-1497-0 · DOI · Paper page
  6. P Michon, 2007, The risk of malarial infections and disease in Papua New Guinean children, Am J Trop Med Hyg, 76, 997, 10.4269/ajtmh.2007.76.997 · DOI · Paper page
  7. TJ Anderson, 2000, Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum, Mol Biol Evol, 17, 1467, 10.1093/oxfordjournals.molbev.a026247 · DOI · Paper page
  8. S Auburn, 2017, Dissecting malaria biology and epidemiology using population genetics and genomics, Int J Parasitol, 47, 77, 10.1016/j.ijpara.2016.08.006 · DOI
  9. AE Barry, 2015, Uncovering the transmission dynamics of Plasmodium vivax using population genetics, Pathog Glob Health, 109, 142, 10.1179/2047773215Y.0000000012 · doi:10.1179/2047773215y.0000000012
  10. Y Hamedi, 2016, Molecular Epidemiology of P. vivax in Iran: High Diversity and Complex Sub-Structure Using Neutral Markers, but No Evidence of Y976F Mutation at pvmdr1., PLoS ONE., 11, e0166124, 10.1371/journal.pone.0166124 · doi:10.1371/journal.pone.0166124
  11. S Gunawardena, 2014, The Sri Lankan paradox: high genetic diversity in Plasmodium vivax populations despite decreasing levels of malaria transmission, Parasitology, 141, 880, 10.1017/S0031182013002278 · doi:10.1017/s0031182013002278
  12. DJ Winter, 2015, Whole Genome Sequencing of Field Isolates Reveals Extensive Genetic Diversity in Plasmodium vivax from Colombia, PLoS Negl Trop Dis, 9, e0004252, 10.1371/journal.pntd.0004252 · DOI
  13. DN Hupalo, 2016, Population genomics studies identify signatures of global dispersal and drug resistance in Plasmodium vivax, Nat Genet, 48, 953, 10.1038/ng.3588 · DOI · Paper page
  14. S Auburn, 2018, Genomic analysis of a pre-elimination Malaysian Plasmodium vivax population reveals selective pressures and changing transmission dynamics., Nat Commun., 9, 2585, 10.1038/s41467-018-04965-4 · DOI · Paper page
  15. E Kenangalem, 2019, Malaria morbidity and mortality following introduction of a universal policy of artemisinin-based treatment for malaria in Papua, Indonesia: A longitudinal surveillance study., PLoS Med., 16, e1002815, 10.1371/journal.pmed.1002815 · DOI
  16. Z Pava, 2020, Molecular surveillance over 14 years confirms reduction of Plasmodium vivax and falciparum transmission after implementation of Artemisinin-based combination therapy in Papua, Indonesia., PLoS Negl Trop Dis., 14, e0008295, 10.1371/journal.pntd.0008295 · doi:10.1371/journal.pntd.0008295
  17. A Waltmann, 2018, Increasingly inbred and fragmented populations of Plasmodium vivax associated with the eastward decline in malaria transmission across the Southwest Pacific., PLoS Negl Trop Dis, 12, e0006146, 10.1371/journal.pntd.0006146 · DOI
  18. JH Kattenberg, 2020, Monitoring Plasmodium falciparum and Plasmodium vivax using microsatellite markers indicates limited changes in population structure after substantial transmission decline in Papua New Guinea, Mol Ecol, 29, 4525, 10.1111/mec.15654 · DOI
  19. R Noviyanti, 2020, Implementing parasite genotyping into national surveillance frameworks: feedback from control programmes and researchers in the Asia-Pacific region., Malar J., 19, 271, 10.1186/s12936-020-03330-5 · DOI · Paper page
  20. JM Sa, 2019, Plasmodium vivax chloroquine resistance links to pvcrt transcription in a genetic cross., Nat Commun., 10, 4300, 10.1038/s41467-019-12256-9 · DOI
  21. RD Pearson, 2016, Genomic analysis of local variation and recent evolution in Plasmodium vivax, Nat Genet, 48, 959, 10.1038/ng.3599 · DOI · Paper page
  22. R Suwanarusk, 2007, Chloroquine resistant Plasmodium vivax: in vitro characterisation and association with molecular polymorphisms., PLoS ONE., 2, e1089, 10.1371/journal.pone.0001089 · DOI · Paper page
  23. JM Sa, 2006, Expression and function of pvcrt-o, a Plasmodium vivax ortholog of pfcrt, in Plasmodium falciparum and Dictyostelium discoideum, Mol Biochem Parasitol, 150, 219, 10.1016/j.molbiopara.2006.08.006 · DOI
  24. GC Melo, 2014, Expression levels of pvcrt-o and pvmdr-1 are associated with chloroquine resistance and severe Plasmodium vivax malaria in patients of the Brazilian Amazon., PLoS ONE., 9, e105922, 10.1371/journal.pone.0105922 · DOI · Paper page
  25. G Snounou, 1998, The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment, Parasitol Today, 14, 462, 10.1016/S0169-4758(98)01340-4 · DOI · Paper page
  26. M Imwong, 2007, Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites, J Infect Dis, 195, 927, 10.1086/512241 · DOI · Paper page
  27. N Chen, 2007, Relapses of Plasmodium vivax infection result from clonal hypnozoites activated at predetermined intervals, J Infect Dis, 195, 934, 10.1086/512242 · DOI · Paper page
  28. AN Cowell, 2018, Exploration of Plasmodium vivax transmission dynamics and recurrent infections in the Peruvian Amazon using whole genome sequencing, Genome Med, 10, 52, 10.1186/s13073-018-0563-0 · DOI · Paper page
  29. J Popovici, 2018, Genomic Analyses Reveal the Common Occurrence and Complexity of Plasmodium vivax Relapses in Cambodia., MBio, 9, e01888, 10.1128/mBio.01888-17 · DOI
  30. AT Bright, 2014, A high resolution case study of a patient with recurrent Plasmodium vivax infections shows that relapses were caused by meiotic siblings., PLoS Negl Trop Dis, 8, e2882, 10.1371/journal.pntd.0002882 · DOI · Paper page
  31. AR Taylor, 2019, Resolving the cause of recurrent Plasmodium vivax malaria probabilistically., Nat Commun., 10, 5595, 10.1038/s41467-019-13412-x · DOI · Paper page
  32. T Bousema, 2012, Hitting hotspots: spatial targeting of malaria for control and elimination., PLoS Med., 9, e1001165, 10.1371/journal.pmed.1001165 · DOI · Paper page
  33. A Wesolowski, 2018, Mapping malaria by combining parasite genomic and epidemiologic data., BMC Med., 16, 190, 10.1186/s12916-018-1181-9 · DOI
  34. HH Chang, 2019, Mapping imported malaria in Bangladesh using parasite genetic and human mobility data., Elife, 8, e43481, 10.7554/eLife.43481 · DOI · Paper page
  35. S Tessema, 2019, Using parasite genetic and human mobility data to infer local and cross-border malaria connectivity in Southern Africa., Elife, 8, e43510, 10.7554/eLife.43510 · DOI · Paper page
  36. KA Gray, 2013, Population genetics of Plasmodium falciparum and Plasmodium vivax and asymptomatic malaria in Temotu Province, Solomon Islands., Malar J., 12, 429, 10.1186/1475-2875-12-429 · DOI
  37. C Koepfli, 2013, A Large Reservoir and Little Population Structure in the South Pacific., PLoS ONE, 8, e66041, 10.1371/journal.pone.0066041 · DOI
  38. R Noviyanti, 2015, Contrasting Transmission Dynamics of Co-endemic Plasmodium vivax and P. falciparum: Implications for Malaria Control and Elimination., PLoS Negl Trop Dis., 9, e0003739, 10.1371/journal.pntd.0003739 · DOI
  39. MU Ferreira, 2007, Population structure and transmission dynamics of Plasmodium vivax in rural Amazonia, J Infect Dis, 195, 1218, 10.1086/512685 · DOI
  40. P Orjuela-Sanchez, 2013, Higher microsatellite diversity in Plasmodium vivax than in sympatric Plasmodium falciparum populations in Pursat, Western Cambodia., Exp Parasitol, 134, 318, 10.1016/j.exppara.2013.03.029 · DOI
  41. MA Pacheco, 2019, Limited differentiation among Plasmodium vivax populations from the northwest and to the south Pacific Coast of Colombia: A malaria corridor?, PLoS Negl Trop Dis., 13, e0007310, 10.1371/journal.pntd.0007310 · DOI
  42. P Manrique, 2019, Microsatellite analysis reveals connectivity among geographically distant transmission zones of Plasmodium vivax in the Peruvian Amazon: A critical barrier to regional malaria elimination., PLoS Negl Trop Dis, 13, e0007876, 10.1371/journal.pntd.0007876 · DOI
  43. P Van den Eede, 2010, Multilocus genotyping reveals high heterogeneity and strong local population structure of the Plasmodium vivax population in the Peruvian Amazon, Malar J, 9, 151, 10.1186/1475-2875-9-151 · DOI
  44. SM Chenet, 2012, Local population structure of Plasmodium: impact on malaria control and elimination, Malar J, 11, 412, 10.1186/1475-2875-11-412 · DOI
  45. R Biek, 2015, Measurably evolving pathogens in the genomic era, Trends Ecol Evol, 30, 306, 10.1016/j.tree.2015.03.009 · DOI · Paper page
  46. S. Wright, 1943, Isolation by Distance., Genetics, 28, 114, 10.1093/genetics/28.2.114 · DOI · Paper page
  47. AR Taylor, 2017, Quantifying connectivity between local Plasmodium falciparum malaria parasite populations using identity by descent., PLoS Genet., 13, e1007065, 10.1371/journal.pgen.1007065 · DOI · Paper page
  48. AR Taylor, 2020, Identity-by-descent with uncertainty characterises connectivity of Plasmodium falciparum populations on the Colombian-Pacific coast., PLoS Genet., 16, e1009101, 10.1371/journal.pgen.1009101 · DOI
  49. NM Anstey, 2012, Plasmodium vivax: clinical spectrum, risk factors and pathogenesis., Adv Parasitol, 80, 151, 10.1016/B978-0-12-397900-1.00003-7 · DOI · Paper page
  50. ML Gatton, 2002, Evaluation of the pyrogenic threshold for Plasmodium falciparum malaria in naive individuals, Am J Trop Med Hyg, 66, 467, 10.4269/ajtmh.2002.66.467 · DOI
  51. S. Kitchen, 1949, Symptomatology: general considerations
  52. BE Barber, 2015, Parasite biomass-related inflammation, endothelial activation, microvascular dysfunction and disease severity in vivax malaria., PLoS Pathog., 11, e1004558, 10.1371/journal.ppat.1004558 · DOI
  53. S Kho, 2019, High Risk of Plasmodium vivax Malaria Following Splenectomy in Papua, Indonesia, Clin Infect Dis, 68, 51, 10.1093/cid/ciy403 · doi:10.1093/cid/ciy403
  54. M Imwong, 2016, Numerical Distributions of Parasite Densities During Asymptomatic Malaria, J Infect Dis, 213, 1322, 10.1093/infdis/jiv596 · DOI
  55. I Harris, 2010, A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting., Malar J., 9, 254, 10.1186/1475-2875-9-254 · DOI · Paper page
  56. Q Cheng, 2015, Systematic review of sub-microscopic P. vivax infections: prevalence and determining factors., PLoS Negl Trop Dis., 9, e3413, 10.1371/journal.pntd.0003413 · DOI
  57. S Barbosa, 2014, Epidemiology of disappearing Plasmodium vivax malaria: a case study in rural Amazonia., PLoS Negl Trop Dis, 8, e3109, 10.1371/journal.pntd.0003109 · DOI
  58. AF Vallejo, 2016, Plasmodium vivax gametocyte infectivity in sub-microscopic infections., Malar J., 15, 48, 10.1186/s12936-016-1104-1 · DOI
  59. CM Moreira, 2015, A systematic review of sub-microscopic Plasmodium vivax infection., Malar J., 14, 360, 10.1186/s12936-015-0884-z · DOI
  60. M Imwong, 2015, The epidemiology of subclinical malaria infections in South-East Asia: findings from cross-sectional surveys in Thailand-Myanmar border areas, Cambodia, and Vietnam., Malar J., 14, 381, 10.1186/s12936-015-0906-x · DOI · Paper page
  61. T Bousema, 2011, Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination, Clin Microbiol Rev, 24, 377, 10.1128/CMR.00051-10 · DOI · Paper page
  62. R Tripura, 2016, Persistent Plasmodium falciparum and Plasmodium vivax infections in a western Cambodian population: implications for prevention, treatment and elimination strategies., Malar J., 15, 181, 10.1186/s12936-016-1224-7 · DOI
  63. K Phommasone, 2020, The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR., Malar J., 19, 4, 10.1186/s12936-019-3091-5 · DOI
  64. FG Tadesse, 2018, The Relative Contribution of Symptomatic and Asymptomatic Plasmodium vivax and Plasmodium falciparum Infections to the Infectious Reservoir in a Low-Endemic Setting in Ethiopia, Clin Infect Dis, 66, 1883, 10.1093/cid/cix1123 · DOI · Paper page
  65. E Rovira-Vallbona, 2017, Predominance of asymptomatic and sub-microscopic infections characterizes the Plasmodium gametocyte reservoir in the Peruvian Amazon., PLoS Negl Trop Dis, 11, e0005674, 10.1371/journal.pntd.0005674 · DOI
  66. A Waltmann, 2015, High Rates of Asymptomatic, Sub-microscopic Plasmodium vivax Infection and Disappearing Plasmodium falciparum Malaria in an Area of Low Transmission in Solomon Islands., PLoS Negl Trop Dis, 9, e0003758, 10.1371/journal.pntd.0003758 · DOI
  67. C Koepfli, 2015, Blood-Stage Parasitaemia and Age Determine Plasmodium falciparum and P. vivax Gametocytaemia in Papua New Guinea., PLoS ONE., 10, e0126747, 10.1371/journal.pone.0126747 · DOI
  68. FP Alves, 2005, Asymptomatic carriers of Plasmodium spp. as infection source for malaria vector mosquitoes in the Brazilian Amazon, J Med Entomol, 42, 777, 10.1603/0022-2585(2005)042[0777:ACOPSA]2.0.CO;2 · DOI · Paper page
  69. CJ Joyner, 2019, Humoral immunity prevents clinical malaria during Plasmodium relapses without eliminating gametocytes, PLoS Pathog, 15, e1007974, 10.1371/journal.ppat.1007974 · DOI
  70. A Machado Siqueira, 2012, Spleen rupture in a case of untreated Plasmodium vivax infection., PLoS Negl Trop Dis, 6, e1934, 10.1371/journal.pntd.0001934 · DOI
  71. B Baro, 2017, Plasmodium vivax gametocytes in the bone marrow of an acute malaria patient and changes in the erythroid miRNA profile, PLoS Negl Trop Dis, 11, e0005365, 10.1371/journal.pntd.0005365 · doi:10.1371/journal.pntd.0005365
  72. T Yangzom, 2012, Malaria control in Bhutan: case study of a country embarking on elimination., Malar J., 11, 9, 10.1186/1475-2875-11-9 · DOI
  73. RR Abeyasinghe, 2012, Malaria control and elimination in Sri Lanka: documenting progress and success factors in a conflict setting, PLoS ONE, 7, e43162, 10.1371/journal.pone.0043162 · DOI
  74. A Erhart, 2005, Epidemiology of forest malaria in central Vietnam: a large scale cross-sectional survey., Malar J., 4, 58, 10.1186/1475-2875-4-58 · DOI · Paper page
  75. A Bhumiratana, 2013, Malaria-associated rubber plantations in Thailand., Travel Med Infect Dis, 11, 37, 10.1016/j.tmaid.2012.11.002 · DOI
  76. R Chuquiyauri, 2012, Socio-demographics and the development of malaria elimination strategies in the low transmission setting, Acta Trop, 121, 292, 10.1016/j.actatropica.2011.11.003 · DOI · Paper page
  77. H Hiwat, 2012, Novel strategies lead to pre-elimination of malaria in previously high-risk areas in Suriname, South America., Malar J, 11, 10, 10.1186/1475-2875-11-10 · DOI
  78. G Carrasco-Escobar, 2019, Use of open mobile mapping tool to assess human mobility traceability in rural offline populations with contrasting malaria dynamics., PeerJ., 7, e6298, 10.7717/peerj.6298 · DOI
  79. V Rougeron, 2020, Human Plasmodium vivax diversity, population structure and evolutionary origin, PLoS Negl Trop Dis, 14, e0008072, 10.1371/journal.pntd.0008072 · DOI
  80. ML Baniecki, 2015, Development of a single nucleotide polymorphism barcode to genotype Plasmodium vivax infections, PLoS Negl Trop Dis, 9, e0003539, 10.1371/journal.pntd.0003539 · DOI · Paper page
  81. C Koepfli, 2015, Plasmodium vivax Diversity and Population Structure across Four Continents, PLoS Negl Trop Dis, 9, e0003872, 10.1371/journal.pntd.0003872 · DOI
  82. JH Kattenberg, 2020, Monitoring of Plasmodium falciparum and Plasmodium vivax using microsatellite markers indicates limited changes in population structure after substantial transmission decline in Papua New Guinea, bioRxiv
  83. H Trimarsanto, 2019, A molecular barcode and online tool to identify and map imported infection with Plasmodium vivax., bioRxiv
  84. D Wang, 2015, Transmission Risk from Imported Plasmodium vivax Malaria in the China-Myanmar Border Region, Emerg Infect Dis, 21, 1861, 10.3201/eid2110.150679 · DOI
  85. E Lo, 2017, Frequent Spread of Plasmodium vivax Malaria Maintains High Genetic Diversity at the Myanmar-China Border, Without Distance and Landscape Barriers, J Infect Dis, 216, 1254, 10.1093/infdis/jix106 · DOI
  86. S Wangchuk, 2016, Where chloroquine still works: the genetic make-up and susceptibility of Plasmodium vivax to chloroquine plus primaquine in Bhutan., Malar J, 15, 277, 10.1186/s12936-016-1320-8 · DOI
  87. P Corran, 2007, Serology: a robust indicator of malaria transmission intensity?, Trends Parasitol, 23, 575, 10.1016/j.pt.2007.08.023 · DOI · Paper page
  88. C Drakeley, 2009, Chapter 5. Potential contribution of sero-epidemiological analysis for monitoring malaria control and elimination: historical and current perspectives., Adv Parasitol., 69, 299, 10.1016/S0065-308X(09)69005-9 · DOI
  89. ZM Idris, 2017, Serological measures to assess the efficacy of malaria control programme on Ambae Island, Vanuatu., Parasit Vectors, 10, 204, 10.1186/s13071-017-2139-z · DOI
  90. T Bousema, 2010, Identification of hot spots of malaria transmission for targeted malaria control, J Infect Dis, 201, 1764, 10.1086/652456 · DOI · Paper page
  91. K Kerkhof, 2016, Serological markers to measure recent changes in malaria at population level in Cambodia., Malar J, 15, 529, 10.1186/s12936-016-1576-z · DOI
  92. RL Dewasurendra, 2017, Effectiveness of a serological tool to predict malaria transmission intensity in an elimination setting., BMC Infect Dis., 17, 49, 10.1186/s12879-016-2164-0 · doi:10.1186/s12879-016-2164-0
  93. DL Doolan, 2009, Acquired immunity to malaria, Clin Microbiol Rev, 22, 13, 10.1128/CMR.00025-08 · DOI · Paper page
  94. CJ Drakeley, 2005, Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure, Proc Natl Acad Sci U S A, 102, 5108, 10.1073/pnas.0408725102 · DOI · Paper page
  95. JB Sarr, 2011, Assessment of exposure to Plasmodium falciparum transmission in a low endemicity area by using multiplex fluorescent microsphere-based serological assays., Parasit Vectors., 4, 212, 10.1186/1756-3305-4-212 · DOI
  96. J Skinner, 2015, Plasmodium falciparum Gametocyte-Specific Antibody Profiling Reveals Boosting through Natural Infection and Identifies Potential Markers of Gametocyte Exposure, Infect Immun, 83, 4229, 10.1128/IAI.00644-15 · DOI
  97. A Poinsignon, 2008, Novel peptide marker corresponding to salivary protein gSG6 potentially identifies exposure to Anopheles bites., PLoS ONE., 3, e2472, 10.1371/journal.pone.0002472 · DOI
  98. AB Sagna, 2013, gSG6-P1 salivary biomarker discriminates micro-geographical heterogeneity of human exposure to Anopheles bites in low and seasonal malaria areas., Parasit Vectors., 6, 68, 10.1186/1756-3305-6-68 · DOI
  99. B Londono-Renteria, 2015, An. gambiae gSG6-P1 evaluation as a proxy for human-vector contact in the Americas: a pilot study., Parasit Vectors., 8, 533, 10.1186/s13071-015-1160-3 · DOI
  100. P Ya-Umphan, 2017, Use of an Anopheles Salivary Biomarker to Assess Malaria Transmission Risk Along the Thailand-Myanmar Border, J Infect Dis, 215, 396
  101. EJM Pollard, 2019, Human exposure to Anopheles farauti bites in the Solomon Islands is not associated with IgG antibody response to the gSG6 salivary protein of Anopheles gambiae., Malar J., 18, 334, 10.1186/s12936-019-2975-8 · doi:10.1186/s12936-019-2975-8
  102. RJ Longley, 2020, Development and validation of serological markers for detecting recent Plasmodium vivax infection, Nat Med, 26, 741, 10.1038/s41591-020-0841-4 · DOI
  103. D. Payne, 1987, Spread of chloroquine resistance in Plasmodium falciparum, Parasitol Today, 3, 241, 10.1016/0169-4758(87)90147-5 · DOI · Paper page
  104. KH Rieckmann, 1989, Plasmodium vivax resistance to chloroquine?, Lancet, 2, 1183, 10.1016/S0140-6736(89)91792-3 · DOI · Paper page
  105. KA Schneider, 2013, Fitness components and natural selection: why are there different patterns on the emergence of drug resistance in Plasmodium falciparum and Plasmodium vivax?, Malar J., 12, 15, 10.1186/1475-2875-12-15 · doi:10.1186/1475-2875-12-15
  106. MJ Grigg, 2016, Efficacy of Artesunate-mefloquine for Chloroquine-resistant Plasmodium vivax Malaria in Malaysia: An Open-label, Randomized, Controlled Trial, Clin Infect Dis, 62, 1403, 10.1093/cid/ciw121 · DOI
  107. RN Price, 2012, Phenotypic and genotypic characterisation of drug-resistant Plasmodium vivax, Trends Parasitol, 28, 522, 10.1016/j.pt.2012.08.005 · DOI
  108. H Trimarsanto, 2017, VivaxGEN: An open access platform for comparative analysis of short tandem repeat genotyping data in Plasmodium vivax Populations., PLoS Negl Trop Dis, 11, e0005465, 10.1371/journal.pntd.0005465 · doi:10.1371/journal.pntd.0005465
  109. C Koepfli, 2009, Evaluation of Plasmodium vivax genotyping markers for molecular monitoring in clinical trials, J Infect Dis, 199, 1074, 10.1086/597303 · DOI · Paper page
  110. NR Abdullah, 2013, Plasmodium vivax population structure and transmission dynamics in Sabah Malaysia., PLoS ONE, 8, e82553, 10.1371/journal.pone.0082553 · DOI
  111. S Getachew, 2015, Variation in Complexity of Infection and Transmission Stability between Neighbouring Populations of Plasmodium vivax in Southern Ethiopia., PLoS ONE., 10, e0140780, 10.1371/journal.pone.0140780 · DOI
  112. Y Hamedi, 2002, Plasmodium vivax malaria in Southeast Iran in 1999–2001: establishing the response to chloroquine in vitro and in vivo., Southeast Asian J Trop Med Public Health, 33, 512
  113. JY Kim, 2016, Further Evidence of Increasing Diversity of Plasmodium vivax in the Republic of Korea in Recent Years., PLoS ONE., 11, e0151514, 10.1371/journal.pone.0151514 · DOI
  114. MW Htun, 2017, Chloroquine efficacy for Plasmodium vivax in Myanmar in populations with high genetic diversity and moderate parasite gene flow, Malar J, 16, 281, 10.1186/s12936-017-1912-y · DOI

Cited by

See all 45

Metadata

Authors
Auburn, S., Cheng, Q., Marfurt, J., & Price, R. N.
Venue
PLOS Medicine
Published
2021-04-23
Volume
18
Issue
4
Pages
e1003560
ISSN
1549-1676
Cited by
45
References
3
Language
en
Funders
  • Bill and Melinda Gates Foundation (OPP1054404)
  • Wellcome Trust (200909)
  • Australian Research Council Georgina Sweet Award for Women in Quantitative Biomedical Science

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.